US 12325703
Fused ring compound as FGFR and VEGFR dual inhibitor
granted A61PA61P35/00
Quick answer
US patent 12325703 (Fused ring compound as FGFR and VEGFR dual inhibitor) held by CGeneTech (Suzhou, China) CO., Ltd. expires Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CGeneTech (Suzhou, China) CO., Ltd.
- Grant date
- Tue Jun 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 05 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P35/00